Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+34.1%/yr
vs -23.6%/yr prior
5Y CAGR
+28.2%/yr
Recent acceleration
Acceleration
+57.7pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $195.99M | +380.4% |
| 2024 | $40.79M | -59.5% |
| 2023 | $100.84M | +24.2% |
| 2022 | $81.20M | -43.1% |
| 2021 | $142.77M | +151.9% |
| 2020 | $56.67M | -93.5% |
| 2019 | $876.12M | +267.7% |
| 2018 | $238.30M | +193.6% |
| 2017 | $81.15M | +47.1% |
| 2016 | $55.17M | - |